Oral-suspension Tamiflu on drug-shortage list

The FDA has added one formulation of Tamiflu to its list of drugs in short supply. The listing is for just the 12mg/ml 25-ml oral suspension for children.

The supply of 75-, 45- and 30-mg Tamiflu capsules is unaffected. 

An increase in demand created the supply status, says spokesperson Tara Iannuccillo of brand-holder Genentech. "All inventory [of the oral suspension] has been shipped," she said by telephone.

"We think there's enough in the marketplace, but there may be pockets that run short." If so, both Genentech and the FDA advise that emergency compounding of an oral suspension from Tamiflu 75-mg capsules is an option, as practiced during a shortage in fall 2009.

- here's the listing

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.